JENNIFER HALL: Open Payments
NPI 1124715891 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 70 payments from 14 companies in 2025. Trend: 2023 $485 · 2024 $861 · 2025 $1,326
Food & beverage: $1,326
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $403 |
| ABBVIE INC. | 25 | $308 |
| Axsome Therapeutics, Inc. | 10 | $153 |
| PFIZER INC. | 5 | $94 |
| Lilly USA, LLC | 4 | $75 |
| Exact Sciences Corporation | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Corium, LLC | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Edwards Lifesciences Corporation | 1 | $27 |
Products named: AIRSUPRA, Auvelity, UBRELVY, VRAYLAR, QULIPTA, FARXIGA, NURTEC ODT, TRINTELLIX.
Industry payments across IN — which companies pay providers there.
